六家整合医疗系统中与2型糖尿病缓解相关的临床与人口学特征:一项回顾性队列研究
基于美国六家大型医疗系统2014—2023年电子健康记录,纳入556,758例使用降糖药的2型糖尿病成人,随访3年。2.9%(16,016例)达到糖尿病缓解,其中36.9%复发。与缓解最强的相关特征为基线未用降糖药、基线HbA1c较低和病程较短。
要点
- 3年随访中2.9%的2型糖尿病成人达到缓解,但缓解者中36.9%复发。
- 基线未用降糖药 vs 用≥3种药与缓解相关(OR 15.9,95%CI 12.1-21.0)。
- 基线HbA1c<7% vs ≥11%(OR 3.1,2.9-3.3)、病程<1年 vs ≥4年(OR 2.6,2.5-2.7)与缓解相关。
核心结论
- 在未接受减重手术的2型糖尿病成人中,糖尿病缓解率较低;与缓解最强的相关特征为降糖药使用较少、基线HbA1c较低和糖尿病病程较短。
- 作者认为这些发现突出显示了可用于识别最可能从针对性干预中获益患者的可操作因素,并提出未来研究应评估缓解的长期持久性及健康影响。
研究设计与样本
- 回顾性队列研究,使用美国六家大型医疗服务提供系统2014—2023年电子健康记录数据。
- 队列纳入556,758例≥18岁、研究入组前2年内至少一次HbA1c测量且有降糖药使用证据的2型糖尿病成人。
- 排除妊娠女性及研究前或研究期间接受减重手术的成人。
- 糖尿病缓解定义为停用降糖药后HbA1c<6.5%持续≥3个月。
- 采用多变量logistic回归识别与2型糖尿病缓解相关的特征。
主要发现
- 3年随访期间,2.9%(16,016例成人)达到2型糖尿病缓解,但缓解者中36.9%复发。
- 与缓解最强的相关特征为基线未接受降糖药 vs 使用三种或以上降糖药(OR 15.9,95%CI 12.1-21.0)。
- 基线HbA1c<7% vs ≥11%与缓解相关(OR 3.1,95%CI 2.9-3.3)。
- 糖尿病病程<1年 vs ≥4年与缓解相关(OR 2.6,95%CI 2.5-2.7)。
临床怎么用
- 原文未据此给出推荐。
- 作者认为降糖药使用较少、基线HbA1c较低和病程较短是可识别最可能从针对性干预中获益患者的可操作因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the real-world frequency and characteristics associated with type 2 diabetes remission in a large and diverse cohort of U.S. adults. RESEARCH DESIGN AND METHODS: This retrospective cohort study used 2014-2023 electronic health record data from six major U.S. health care delivery systems. The cohort included 556,758 adults (≥18 years) with type 2 diabetes who had one or more HbA1c measurement in 2 years before study entry and evidence of glucose-lowering medication use. Pregnant women or adults who underwent bariatric surgery before or during the study were excluded. Type 2 diabetes remission was defined as HbA1c <6.5% persisting for ≥3 months after cessation of glucose-lowering medications. Multivariate logistic regression was used to identify characteristics associated with type 2 diabetes remission. RESULTS: Over a 3-year follow-up, 2.9% (16,016 adults) achieved type 2 diabetes remission, although 36.9% of those who experienced remission relapsed. The strongest characteristics associated with remission were not receiving glucose-lowering medications at baseline versus three or more medications (odds ratio [OR] 15.9, 95% CI 12.1-21.0), baseline HbA1c <7% vs. ≥11% (OR 3.1, 2.9-3.3) and diabetes duration <1 year versus ≥4 years (OR 2.6, 2.5-2.7). CONCLUSIONS: Type 2 diabetes remission was low among adults without bariatric surgery. The strongest associated characteristics were fewer diabetes medications, lower baseline HbA1c, and shorter diabetes duration. These findings highlight actionable factors to identify patients who may benefit most from targeted interventions. Future research should evaluate the long-term durability and health impacts of remission.
引用
- Thapa B, Schmittdiel JA, Arterburn D, et al. Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study. Diabetes Care. 2025. PMID: 40734551. doi:10.2337/dc25-0530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。